Entourage Health Announces Amendment to Key Supply Agreement
TORONTO, Sept. 15, 2023 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company“), a Canadian producer and distributor of award-winning cannabis products, announced it has entered into an amended supply agreement (the “Supply Agreement”) with HEXO Corp. (“HEXO”). The amendments, amongst other things, extend the initial term of the agreement, securing Entourage’s ongoing access to high-quality bulk cannabis biomass for its product portfolio. The prices of all products supplied under the Supply Agreement are fixed but subject to limited and periodical adjustments depending on prevailing production costs.
Related news for (ETRGF)
- Entourage Health Corp. Announces Closing of Plan of Arrangement
- Entourage Health Increases Senior Secured Credit Facility
- Entourage Health Corp. Announces Shareholder Approval of Going-Private Transaction
- Entourage Health Corp. Enters into Arrangement Agreement for Going-Private Transaction
- Entourage Health Reports Strong Third Quarter 2024 Financial Results